Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Treprostinil in Idiopathic Pulmonary Fibrosis: NCT05255991 Clinical Landscape Report 2026
9 min read
Treprostinil in Idiopathic Pulmonary Fibrosis: NCT05255991 Clinical Landscape Report 2026
16 October 2026
NCT05255991 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
AB1 in Anemia, Sickle Cell: NCT05261711 Clinical Landscape Report 2026
9 min read
AB1 in Anemia, Sickle Cell: NCT05261711 Clinical Landscape Report 2026
16 October 2026
NCT05261711 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences) in Hemophilia A: NCT05265286 Clinical Landscape Report 2026
9 min read
PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences) in Hemophilia A: NCT05265286 Clinical Landscape Report 2026
16 October 2026
NCT05265286 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Nipocalimab-aahu in Myasthenia Gravis: NCT05265273 Clinical Landscape Report 2026
9 min read
Nipocalimab-aahu in Myasthenia Gravis: NCT05265273 Clinical Landscape Report 2026
16 October 2026
NCT05265273 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Hematopoietic Stem Cell Transplantation Gene Therapy(Christian Medical College) in Hemophilia A: NCT05265767 Clinical Landscape Report 2026
9 min read
Hematopoietic Stem Cell Transplantation Gene Therapy(Christian Medical College) in Hemophilia A: NCT05265767 Clinical Landscape Report 2026
16 October 2026
NCT05265767 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Emicizumab in Hemophilia A: NCT05279924 Clinical Landscape Report 2026
9 min read
Emicizumab in Hemophilia A: NCT05279924 Clinical Landscape Report 2026
16 October 2026
NCT05279924 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Avenciguat in Hepatitis A: NCT05282121 Clinical Landscape Report 2026
9 min read
Avenciguat in Hepatitis A: NCT05282121 Clinical Landscape Report 2026
16 October 2026
NCT05282121 clinical landscape for Hepatitis A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mitapivat in Hematologic Diseases: PACTR202203740886208 Clinical Landscape Report 2026
9 min read
Mitapivat in Hematologic Diseases: PACTR202203740886208 Clinical Landscape Report 2026
16 October 2026
PACTR202203740886208 clinical landscape for Hematologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Prosetin in Amyotrophic Lateral Sclerosis: NCT05279755 Clinical Landscape Report 2026
9 min read
Prosetin in Amyotrophic Lateral Sclerosis: NCT05279755 Clinical Landscape Report 2026
16 October 2026
NCT05279755 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Pentoxifylline in Metabolic Dysfunction Associated Steatohepatitis: NCT05284448 Clinical Landscape Report 2026
9 min read
Pentoxifylline in Metabolic Dysfunction Associated Steatohepatitis: NCT05284448 Clinical Landscape Report 2026
16 October 2026
NCT05284448 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
Read →
Hydroxycarbamide in Anemia, Sickle Cell: NCT05285917 Clinical Landscape Report 2026
9 min read
Hydroxycarbamide in Anemia, Sickle Cell: NCT05285917 Clinical Landscape Report 2026
16 October 2026
NCT05285917 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Freeze-dried Concentrated Human Blood Coagulation Factor IX(Japan Blood Products Organization) in Hemophilia A: NCT05281718 Clinical Landscape Report 2026
9 min read
Freeze-dried Concentrated Human Blood Coagulation Factor IX(Japan Blood Products Organization) in Hemophilia A: NCT05281718 Clinical Landscape Report 2026
16 October 2026
NCT05281718 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →